Total
0
Shares
Cannabix (CSE:BLO) to beta test its THC Breath Analyzer in the U.S.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cannabix Technologies (BLO) will begin beta testing its marijuana breathalyzer with a private clinic in the Northwestern U.S.
  • Beta testing will focus on training the device’s machine learning database, determining sensitivity ranges and usability
  • The clinic is one of the top drug testing providers to employers in its state
  • The company expects to deliver its version 3.0 THC Breath Analyzer prototype to the clinic in the coming weeks
  • Cannabix Technologies develops marijuana breathalyzers for law enforcement and the workplace
  • Cannabix Technologies (BLO) is up 7.24 per cent and is currently trading at C$1.63 per share

Cannabix Technologies (BLO) will begin beta testing its marijuana breathalyzer with a private clinic in the Northwestern U.S.

Cannabix's THC Breath Analyzer allows for the quick, easy and non-invasive testing for recent use of THC, the psychoactive component of marijuana.

Beta testing will focus on training the device’s machine learning database, determining sensitivity ranges and usability.

The data will also help with identifying cross-reactivity of other substances with the study population.

Cannabix expects to deliver its version 3.0 THC Breath Analyzer prototype to the clinic in the coming weeks.

The clinic has a robust drug testing operation and is one of the top drug testing providers to employers in its state. It serves a diverse range of patients and focuses on private sector testing for alcohol and illicit drugs.

The clinic also has extensive experience beta testing new drug testing technologies, including oral swab devices which have been authorized for use in certain jurisdictions.

Studies have shown that breath is a better indicator of impairment than saliva and urine because THC is present in breath for only 1-3 hours, while it can be detected in other bodily fluids for days or even weeks after smoking. This short detection period in the breath aligns with the peak impairment window.

Cannabix and the clinic have entered into a non-disclosure agreement.

Cannabix Technologies develops marijuana breathalyzers for law enforcement and the workplace. 

Cannabix Technologies (BLO) is up 7.24 per cent and is currently trading at C$1.63 per share as of 9:44 am ET.

More From The Market Herald
OverActive Media’s (TSXV:OAM) Toronto Ultra wins Property of the Year

" OverActive Media’s (TSXV:OAM) Toronto Ultra wins Property of the Year

OverActive’s (OAM) esports team, Toronto Ultra, has won the 2021 Sponsorship Marketing Award for Property of the Year.
Fandoms Sports Media puts Esports app to the test

" Intema Solutions (TSXV:ITM) closes acquisition of esports team

Intema Solutions (ITM) has completed its acquisition of the owner of the Team BH esports team, Team Bloodhounds Inc.
LUXXFOLIO (CSE:LUXX) announces DTC eligibility and listing on the Börse Berlin

" LUXXFOLIO (CSE:LUXX) announces DTC eligibility and listing on the Börse Berlin

LUXXFOLIO Holdings (LUXX) has received confirmation that its common shares are now eligible to be electronically cleared and settled through the DTC.
DGTL Holdings (TSXV:DGTL) announces delay in filing of annual financial statements

" DGTL Holdings (TSXV:DGTL) announces delay in filing of annual financial statements

DGTL Holdings (DGTL) will not meet the deadline for filing the company’s audited financial statements and management discussion & analysis.